Fisher Asset Management’s Protara Therapeutics TARA Stock Holding History

Fisher Asset Management’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$380K	Buy	+99,566	New	+$474K	﹤0.01%	871

Other funds holding TARA

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Fisher Asset Management's TARA Position: Q2 2026 in Review

Fisher Asset Management opened a new position in Protara Therapeutics (TARA) in Q2 2026: 99,566 shares worth $380K. The stake represents ﹤0.01% of the portfolio and ranks #871 among its holdings.

21 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

Fisher Asset Management held 99,566 shares of Protara Therapeutics worth $380K as of Q2 2026.
Protara Therapeutics was a new Fisher Asset Management position in Q2 2026.
Protara Therapeutics made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #871 holding.
21 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.